← Docebo Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (Note 14) | $41.4m | $62.9m | $104.2m | $142.9m | $180.8m | $216.9m | $242.7m | — | |
| Cost of revenue (Note 15) | $8.4m |
$11.5m
+37.94%
|
$20.8m
+80.14%
|
$28.2m
+35.56%
|
$34.5m
+22.43%
|
$41.3m
+19.70%
|
$47.9m
+15.88%
|
$53.3m
+11.47%
|
|
| Gross profit | $33.1m |
$51.4m
+55.32%
|
$83.5m
+62.44%
|
$114.7m
+37.48%
|
$146.3m
+27.55%
|
$175.6m
+20.02%
|
$194.8m
+10.93%
|
$205.6m
+5.52%
|
|
| Research and development | $9.4m | $13.0m | $20.4m | $24.8m | $35.5m | $43.9m | $50.1m | $52.5m | |
| Sales and marketing | $18.0m | $24.0m | $43.3m | $59.7m | $67.2m | $69.5m | $76.4m | — | |
| General and administrative | $13.1m | $17.0m | $28.4m | $30.2m | $33.8m | $32.6m | $34.7m | $45.6m | |
| Operating expenses | $42.9m | $58.6m | $96.9m | $110.5m | $150.1m | $154.3m | $171.6m | $183.2m | |
| Operating income | ($9.8m) |
($7.3m)
+25.94%
|
($13.4m)
-85.12%
|
$4.2m
+131.12%
|
($3.7m)
-188.65%
|
$21.3m
+673.91%
|
$23.2m
+9.13%
|
$22.4m
-3.67%
|
|
| Other income, net | — | — | — | ($85k) | $181k | ($17k) | ($2k) | ($3.9m) | |
| Income before income taxes | $11.3m | $7.3m | ($13.4m) | $7.8m | $4.8m | $23.7m | $24.4m | $17.0m | |
| Income tax (recovery) expense (Note 17) | $609k | $336k | $172k | $764k | $2.0m | ($3.0m) | ($13.1m) | — | |
| Net income | ($11.9m) |
($7.7m)
+35.76%
|
($13.6m)
-77.70%
|
$7.0m
+151.60%
|
$2.8m
-59.53%
|
$26.7m
+841.41%
|
$37.5m
+40.31%
|
$33.6m
-10.43%
|
|
| Earnings per share - basic (Note 12) (in dollars per share) | ($0.49) | ($0.26) | ($0.41) | $0.21 | $0.09 | $0.88 | $1.31 | $1.18 | |
| Earnings per share - diluted (Note 12) (in dollars per share) | ($0.49) | ($0.26) | ($0.41) | $0.21 | $0.08 | $0.86 | $1.28 | $1.15 | |
| Weighted average number of common shares outstanding - basic (Note 12) (in shares) | 24.4m | 28.9m | 32.9m | 33.1m | 32.5m | 30.3m | 28.7m | — | |
| Weighted average number of common shares outstanding - diluted (Note 12) (in shares) | 24.4m | 28.9m | 32.9m | 34.0m | 33.7m | 31.0m | 29.4m | — | |
| Other comprehensive income | |||||||||
| Share-based compensation (Note 12) | $659k | $1.6m | $2.3m | $4.7m | $6.0m | $7.3m | $6.0m | — | |
| Foreign exchange loss (gain) | $922k | $1.8m | $473k | ($11.1m) | $4.4m | ($2.4m) | $1.2m | — | |
| Depreciation and amortization (Note 5, 6 and 7) | $693k | $1.2m | $2.0m | $2.3m | $3.1m | $3.4m | $3.2m | $5.7m | |
| Finance income, net (Note 9) | $796k | $130k | $65k | ($3.5m) | ($8.7m) | ($2.4m) | ($1.2m) | — | |
| Exchange (gain) loss on translation of foreign operations | ($652k) | ($1.0m) | ($494k) | $11.9m | ($4.0m) | $3.4m | ($1.5m) | — | |
| Actuarial gain (Note 10) | $110k | $108k | $80k | ($252k) | $330k | ($58k) | ($388k) | — | |
| Comprehensive income | ($11.4m) | ($6.8m) | ($13.2m) | ($4.7m) | $6.5m | $23.4m | $39.4m | — |